Top Markets
#1 Islamic Coin Islamic Coin +152.22%
#2 Bitway Bitway +56.40%
#3 Wrapped STX (Velar) Wrapped STX (Velar) +37.87%
#4 Starpower Starpower +37.09%
#5 Pons Pons +20.76%
#6 aelf aelf +19.45%
#7 Pleasing Gold Pleasing Gold +17.80%
#8 Venom Venom +15.10%
#9 Decred Decred +14.18%
#10 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +14.08%
Coin of the day
Islamic Coin Islamic Coin
설정
언어
한국어
통화
USD
테마
Satsuma Pharmaceuticals, Inc. Satsuma Pharmaceuticals, Inc.

Satsuma Pharmaceuticals, Inc.

STSA
주식 순위 #29910
Satsuma Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm... Satsuma Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm dedicated to developing innovative therapies for the rapid relief of migraines. Its lead therapeutic candidate, STS101, is an integrated drug-device system comprising a proprietary dry-powder formulation of dihydroergotamine mesylate. Currently, STS101 is progressing through its pivotal SUMMIT Phase 3 efficacy trials and is designed for self-administration via a specialized, pre-filled, single-use nasal delivery device. Established in 2016, the company maintains its headquarters in South San Francisco, California.
주가
$1.10
마지막 동기화: 2023-06-07
시가총액
$19.12M
변동 (1일)
-0.90%
변동 (1년)
0.00%
국가
US
거래 Satsuma Pharmaceuticals, Inc. (STSA)

카테고리

Healthcare
Satsuma Pharmaceuticals, Inc. (STSA)의 EPS
2026 기준 EPS TTM: 0
Satsuma Pharmaceuticals, Inc.의 최신 재무 보고서와 주가에 따르면, 현재 EPS (TTM)는 0입니다. 2026년 말에는 회사의 EPS가 0였으며, 이는 2026년의 EPS 0와 동일입니다.
Satsuma Pharmaceuticals, Inc.의 EPS 기록 (2026 ~ 2026)
매년 말의 EPS
연도 EPS 변화
제공된 날짜에 대한 데이터가 충분하지 않습니다.
유사 기업 또는 경쟁사의 EPS
회사 EPS EPS 차이 국가
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $17.32 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $27.74 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $2.98 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR